Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia

Oudart, JB; Djerada, Z; Nonnonhou, V; Badr, S; Bertholon, LA; Dammak, A; Jaidi, Y; Novella, JL; Pallet, N; Gillery, P; Mahmoudi, R

Mahmoudi, R (corresponding author), Reims Univ Hosp, Maison Blanche Hosp, Champagne Ardenne Resource & Res Memory Ctr CMRR, Reims, France.; Mahmoudi, R (corresponding author), Reims Univ Hosp, Maison Blanche Hosp, Dept Internal Med & Geriatr, Reims, France.; Mahmoudi, R (corresponding author), Univ Reims, Fac Med, Reims, France.

FRONTIERS IN NEUROLOGY, 2020; 11 ():

Abstract

Background:Cerebrospinal fluid (CSF) biomarkers are used to diagnose Alzheimer disease (AD), especially in atypical clinical presentations. No consens......

Full Text Link